Everything below concerns synthetic heptapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-06-06. Numbers and descriptions here follow the published literature rather than marketing material.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its chain combines the first seven residues of corticotropin with a C-terminal proline-glycine-proline extension, a modification intended to slow enzymatic breakdown. The free peptide has a molecular mass near 813.9 daltons. It belongs to the class of ACTH-derived fragments studied for central nervous system activity rather than for adrenal steroid stimulation. This structural relationship to a natural hormone fragment is the usual starting point for describing the compound in the literature.
Development took place during the 1980s at institutes of the Russian Academy of Sciences, where peptide fragments of ACTH were screened for cognitive and neuroprotective effects. The compound received regulatory approval in Russia as a nasal preparation, marketed for conditions such as ischemic stroke, transient ischemic attacks, and optic nerve disorders. Registration in other countries has not followed. Most published clinical reports originate from a small number of Russian research groups, and independent replication outside that setting remains limited. The regulatory status therefore differs sharply between Russia and the rest of the world.
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
| Property | Value | Notes |
|---|---|---|
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro | Heptapeptide; ACTH(4-10) analog extended at C-terminus |
| Molecular mass | ~813.9 Da | Free peptide, unmodified |
| Appearance | White to off-white powder | Typical lyophilized solid |
| Solubility | Soluble in water and saline | Also soluble in common aqueous buffers |
| Storage (solid) | -20 °C, desiccated | Protect from moisture and repeated thawing |
Published research on this peptide originates mainly from Russian laboratories, and the wider international literature is comparatively thin. Studies have used rodent models of stroke, hypoxia, and memory tasks, with a smaller number of human trials reported. Reported outcomes include changes in attention and memory measures, along with effects on neurotrophic factor expression in some experiments. Small sample sizes, inconsistent dosing protocols, and limited independent replication are widely noted limitations, so the strength of the clinical evidence remains an open question.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues correspond to the ACTH(4-10) fragment, while the terminal Pro-Gly-Pro extension was added to improve metabolic stability. Its molecular formula is C37H51N9O10S and its monoisotopic mass is approximately 813.9 Da. The compound is classified as a peptide research chemical and as a registered pharmaceutical product in Russia, but it does not hold marketing approval in the European Union or the United States. Naming conventions vary across supplier catalogs.
Laboratory descriptions of the material are consistent across suppliers. It appears as a white to off-white lyophilized powder that dissolves readily in water and in polar organic solvents such as dimethyl sulfoxide. Aqueous solutions are clear and colorless at low concentrations. Because the peptide contains methionine, oxidation at the sulfur atom is a recognized degradation pathway, and handling notes usually call for protected, desiccated storage. Reported purity for research-grade lots is generally above 95 percent as measured by reversed-phase high-performance liquid chromatography.
The compound is registered in Russia as a pharmaceutical product, most commonly formulated as a nasal solution, and has been used in that setting since the 1990s. Outside that jurisdiction it is generally handled as a research chemical rather than an approved medicine. Regulatory status therefore differs sharply between countries, and material sold internationally may not correspond to the Russian pharmaceutical formulation. Documentation with commercial samples is typically limited to a certificate of analysis covering purity and identity, not clinical status or local legal classification.
=== Health effects === Research starting in 1975 showed substantially increased risk of endometrial cancer. Since 1976, the drug has carried a label warning about the risk. As part of the Women's Health Initiative sponsored by the National Institutes of Health, a large-scale clinical trial of menopausal HRT showed that long-term use of estrogen and a progestin may increase the risk of strokes, heart attacks, blood clots, and breast cancer. Following these results, Wyeth experienced a significant decline in its sales of Premarin, Prempro (CEEs and medroxyprogesterone acetate), and related products, from over $2 billion in 2002 to just over $1 billion in 2006.
=== Clinical environment === Guidelines from the UCSF Transgender Care Center state the importance of visibility in chosen gender identity for transgender or non-binary patients. Safe environments include a two-step process in collecting gender identity data by differentiating between personal identity and assignments at birth for medical histories. Common techniques recommended are asking patients their preferred name, pronouns, and other names they may go by in legal documents. In addition, visibility of non-cisgender identities is defined by the work environment of the clinic. Front-desk staff and medical assistants will interact with patients, for which these guidelines recommend appropriate training. The existence of at least one gender-neutral bathroom also shows consideration of patients with non-binary gender identities.
=== Library of the School of Medicine === The School of Medicine at the University of Patras have an independent library to be used from the student's community of the School. The library provides a reading room (150 seats), a copy machine with charge of use and computers. Users may also borrow books from the library as long as they have the library card.
== Characterization == Atomic force microscopy can measure the mechanical properties of nanotubes. Scanning-electron and atomic-forces microscopy are used to examine Lego peptide nanofiber structures. Dynamic light scattering studies show structures of surfactant peptides. Surfactant peptides have been studied using a quick-freeze/deep–etch sample preparation method which minimizes effects on the structure. The sample nanostructures are flash frozen at −196 °C and can be studied three-dimensionally, using Transmission electron microscopy. Using computer technology, a molecular model of peptides and their interactions can be built and studied. Specific tests can be performed on certain peptides: for example, a fluorescent emission test could be applied to amyloid fibrils by using the dye Thioflavin T, which binds specifically to the peptide and emits blue fluorescence when excited.
Sources: en.wikipedia.org
=== Lancelet === Upon amputation, lancelet tails healed and formed a blastema structure, suggesting dedifferentiation of cells to prepare for regeneration. Lancelets can regenerate anterior and posterior structures, including neural tube, notochord, fin, and muscle The blastema that is formed expresses PAX3 and PAX7, which is associated with activation of muscle stem cells. This specific invertebrate model seems to be limited in its dedifferentiation abilities with size and age. The older and larger the animal is, the less apt it is for dedifferentiation.
=== Sa–Sc === Margarita Salas (1938–2019). Spanish biochemist at the Spanish National Research Council. Known for work on DNA replication. First woman elected to the Royal Spanish Academy. Wolfram Saenger (1939–2026). German biochemist and protein crystallographer at the Free University of Berlin, known for work on membrane proteins and protein-nucleic acid complexes. Member Natl. Acad. Sci. USA Frederick Sanger FRS (1918–2013). British biochemist at Cambridge University, known for advances in sequencing proteins and nucleic acids. Nobel prizes in Chemistry (1958, 1980). Foreign Associate Natl. Acad. Sci. USA. Albert Schatz (1920–2005). American microbiologist and science educator at Temple University, the discoverer of the antibiotic streptomycin. Paul Schimmel (b. 1940). American biochemist at the Scripps Research Institute, who developed methods of nucleic acid sequencing and coauthored (with Charles Cantor) the very influential three-volume book Biophysical Chemistry. Member Natl. Acad. Sci. USA Rudolph Schoenheimer (1898–1941). German-American biochemist at Columbia, pioneer of radioactive tagging of molecules. Stefan Schuster (b. 1961). German biophysicist at the University of Jena, pioneer in metabolic control analysis and metabolic pathway analysis. Rose Scott-Moncrieff (1903–1991). British biochemical geneticist at the University of Cambridge.
== Interactions == Bempedoic acid does not interact with the cytochrome P450 enzyme system in the liver and only weakly inhibits the transporter proteins SLCO1B1, SLCO1B3 and SLC22A7 (the latter possibly being responsible for the increase of uric acid in the blood, and therefore the adverse effect gout). Despite this, the drug increases blood levels of statins. The effect is most pronounced with simvastatin and pravastatin, whose AUC is increased about twofold. No other clinically relevant interactions have been found in studies.
Helmut Schwarz (born 6 August 1943) is a German organic chemist. He has been a professor of chemistry at the Technische Universität Berlin since 1978. In 2018, he was elected a foreign associate of the U.S. National Academy of Sciences.
=== Energy released === The average energy released per fission of uranium-233 is about 197.9 MeV = 3.171·10−11 J (i.e. 19.09 TJ/mol = 81.95 TJ/kg = 22764 MWh/kg that is 1.8 million times more than the same mass of diesel).
Sources: en.wikipedia.org
=== Nootropic or "smart drug" === Selegiline is considered by some to be a nootropic, otherwise known as a cognitive enhancer or "smart drug", both at clinical and sub-clinical dosages, and has been used off-label and non-medically to improve cognitive performance. It is one of the most popular such agents. Selegiline has been found to have neuroprotective activity against certain neurotoxins and to increase the production of several brain growth factors, such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell line-derived neurotrophic factor (GDNF). The drug has also been found in animal models to improve learning ability and to help preserve it during ischemia and aging. Despite claims that selegiline and other claimed nootropics have cognitive-enhancing effects however, these effects are controversial and their benefits versus risks are uncertain.
== Books and photographs == Levé's first book, Oeuvres (2002), is an imaginary list of more than 500 non-existent conceptual artworks by the author, although some of the ideas were taken up as the premises of later projects actually completed by Levé (for example the photography books Amérique and Pornographie). Levé traveled in the United States in 2002, writing Autoportrait and taking the photographs for the series Amérique, which pictures small American towns named after cities in other countries. Autoportrait consists entirely of disconnected, unparagraphed sentences of the authorial speaker's assertions and self-description, a "collection of fragments" by a "literary cubist." His final book, Suicide, although fictional, evokes the suicide of his childhood friend 20 years earlier, which he had also mentioned in "a shocking little addendum, tucked nonchalantly...into Autoportrait." He delivered the manuscript to his editor ten days before he took his own life at 42 years old.
Thioesters exhibit electrosteric repulsive forces due to amine functional groups and their size, which prevents aggregation. These electrostatic repulsive forces are weakened by counterions in solution, such as Ca2+ found in seawater. Ca2+ ions are naturally found in seawater due to the weathering of calcareous rocks, and allow for dissolution of the oxide-coated particle at low electrolyte concentrations. This leads to the aggregation of silver nanoparticles onto thioesters in seawater. When aggregation occurs, the silver nanoparticles lose microbial toxicity, but have greater exposure in the environment for larger organisms. These effects have not been completely identified, but may be hazardous to an organism's health via biological magnification.
238Pu due to its much shorter half life heats up to much higher temperatures and glows red hot with blackbody radiation if left without external heating or cooling. This heat has been used in radioisotope thermoelectric generators (see below). The resistivity of plutonium at room temperature is very high for a metal, and it gets even higher with lower temperatures, which is unusual for metals. This trend continues down to 100 K, below which resistivity rapidly decreases for fresh samples. Resistivity then begins to increase with time at around 20 K due to radiation damage, with the rate dictated by the isotopic composition of the sample. Because of self-irradiation, a sample of plutonium fatigues throughout its crystal structure, meaning the ordered arrangement of its atoms becomes disrupted by radiation with time. Self-irradiation can also lead to annealing which counteracts some of the fatigue effects as temperature increases above 100 K. Unlike most materials, plutonium increases in density when it melts – by 2.5% – but the liquid metal exhibits a linear decrease in density with temperature. Near the melting point, the liquid plutonium has very high viscosity and surface tension compared to other metals.
Sources: en.wikipedia.org
Semax is a synthetic seven-amino-acid peptide derived from a fragment of corticotropin. It is used in Russia as a nasal preparation, while elsewhere it is studied as a research compound. It is not approved as a medicine in most countries.
Its sequence corresponds to the 4-10 region of corticotropin extended by three residues. This fragment lacks the region responsible for adrenal steroid release, so it is explored for neural rather than hormonal effects. The relationship explains the compound's classification among ACTH-derived peptides.
It holds approval in Russia for several neurological indications as a nasal spray or drop formulation. Regulatory agencies in the United States and the European Union have not approved it. Products sold elsewhere are generally labeled for research use only.
It is a synthetic seven-amino-acid peptide built from the ACTH(4-7) sequence plus a Pro-Gly-Pro tail. It belongs to the family of short ACTH fragments studied for nervous-system effects. Its backbone contains only standard amino acids.